Results of the "Ocular hypertension treatment study" [Ergebnisse der "Ocular hypertension treatment study" (OHTS)]

被引:0
|
作者
Pfeiffer N. [1 ,2 ]
机构
[1] Augenklinik, Universität, Mainz
[2] Augenklinik, Universität, 55131 Mainz
来源
Der Ophthalmologe | 2005年 / 102卷 / 3期
关键词
Intraocular pressure; Ocular hypertension; Ocular hypertension treatment study; Primary open-angle glaucoma; Risk factors;
D O I
10.1007/s00347-004-1150-x
中图分类号
学科分类号
摘要
Ocular hypertension (OHT) is defined as intraocular pressure (IOP) elevated above normal levels which occurs without detectable damage to the papilla or visual field. It is considered to be the most important risk factor for developing primary open-angle glaucoma (POAG). The .,Ocular hypertension treatment study" (OHTS) addresses the issue of whether lowering IOC before damage to the papilla or visual field occurs can hinder their development and whether OHT can be treated categorically. This randomized, prospective, nonmasked and non-placebo-controlled, multicenter study documents the protective effect of prophylactic lowering of IOC and identifies and explains the risk factors for developing POAG. These include advancing age, reduced corneal thickness, increased pattern standard deviations in white-on-white perimetry, and elevated vertical or horizontal cup to disc ratio. Due to the large individual differences in risk distribution and the very high costs of treating OHT, the question of whether OHT should be treated on principle remains open in the OHTS. This decision must be made on an individual basis after each patient's risk has been assessed. © Springer Medizin Verlag 2005.
引用
收藏
页码:230 / 234
页数:4
相关论文
共 50 条
  • [41] The Ocular Hypertension Treatment Study Calculator in an African American Population
    Sankar, Prithvi
    Cui, Qi J.
    Breen, Carly
    Woo, Frank
    Vilson, Fred
    Williams, Alexis
    May, Dionne
    Petrides, Athena
    Lee, Roy
    Miller-Ellis, Eydie G.
    Lehman, Amanda
    Addis, Victoria
    O'Brien, Joan M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [42] The Rate of Visual Field Change in the Ocular Hypertension Treatment Study
    Demirel, Shaban
    De Moraes, Carlos Gustavo V.
    Gardiner, Stuart K.
    Liebmann, Jeffrey M.
    Cioffi, George A.
    Ritch, Robert
    Gordon, Mae O.
    Kass, Michael A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2012, 53 (01) : 224 - 227
  • [43] The Ocular Hypertension Treatment Study: Aging and Reliability of Visual Fields
    Gordon, Mae O.
    Huecker, Julia
    Plumb, Kimberly
    Lemming, Laura
    Kass, Michael A.
    Keltner, John L.
    Wall, Michael
    Johnson, Chris A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [44] Baseline visual field characteristics in the ocular hypertension treatment study
    Johnson, CA
    Keltner, JL
    Cello, KE
    Edwards, M
    Kass, MA
    Gordon, MO
    Budenz, DL
    Gaasterland, DE
    Werner, E
    OPHTHALMOLOGY, 2002, 109 (03) : 432 - 437
  • [45] Risk Calculation in the Medication Arm of the Ocular Hypertension Treatment Study
    Leshno, Ari
    De Moraes, Carlos Gustavo
    Ciof, George A.
    Kass, Michael
    Gordon, Mae
    Liebmann, Jeffrey M.
    OPHTHALMOLOGY GLAUCOMA, 2023, 6 (06): : 592 - 598
  • [46] Rates of Change of Mean Deviation in the Ocular Hypertension Treatment Study
    Demirel, S.
    de Moraes, C. G.
    Gardiner, S. K.
    Liebmann, J. M.
    Cioffi, G. A.
    Ritch, R.
    Gordon, M. O.
    Kass, M. A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [47] The Incidence of Retinal Vein Occlusion in the Ocular Hypertension Treatment Study
    Barnett, Edward M.
    Fantin, Aldo
    Wilson, Bradley S.
    Kass, Michael A.
    Gordon, Mae O.
    OPHTHALMOLOGY, 2010, 117 (03) : 484 - 488
  • [48] Clinical Application of the 20-Year Results from the Ocular Hypertension Treatment Study
    Anderson, Douglas R.
    JAMA OPHTHALMOLOGY, 2021, 139 (10) : 1146 - 1146
  • [49] Incidence of Glaucomatous Visual Field Loss Subsequent to Initial Glaucomatous Optic Disc Deterioration in the Ocular Hypertension Treatment Study (OHTS)
    Kass, M. A.
    Gordon, M. O.
    Huecker, J. A.
    Keltner, J.
    Parrish, R.
    Johnson, C. A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [50] Effect of Treatment on Rates of Visual Field Change in the Ocular Hypertension Treatment Study
    De Moraes, C. G.
    Demirel, S.
    Gardiner, S. K.
    Liebmann, J. M.
    Cioffi, G. A.
    Ritch, R.
    Gordon, M. O.
    Kass, M. A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)